Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Minoxidil and spironolactone can improve hair growth, but responses vary and side effects are common.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Alopecia areata causes hair loss and has various treatment options, but responses differ.

The claimant sued for negligence after a hair treatment caused harm and distress, and the defendant responded after legal action started.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Trichogram is useful for diagnosing hair disorders, but newer, non-invasive methods like trichoscopy are becoming more popular due to their sensitivity and ability to monitor treatment responses.

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Loose anagen hair syndrome in children may improve with age, but treatment results vary.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Onabotulinumtoxin-A effectively treated a painful scalp condition when other treatments failed.

Men with hair loss feel it affects their emotions and life quality, and want more effective treatments.

Platelet-rich plasma treatment can significantly increase hair count and density in men with pattern baldness, and these improvements can last up to 3 months.

The effects of estrogen on human hair growth are unclear and need more research.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

There is no standard treatment for CCCA, and practices vary widely.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

Women also use 5α-reductase inhibitors, and their effects differ from men.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Human hair contains diverse proteins, including keratins and histones, which could help assess hair health and aging.

PRP with microneedling effectively treats hair loss, and dermoscopy helps evaluate results.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.